Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

325 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team.
Staszewski S, Morales-Ramirez J, Tashima KT, Rachlis A, Skiest D, Stanford J, Stryker R, Johnson P, Labriola DF, Farina D, Manion DJ, Ruiz NM. Staszewski S, et al. Among authors: ruiz nm. N Engl J Med. 1999 Dec 16;341(25):1865-73. doi: 10.1056/NEJM199912163412501. N Engl J Med. 1999. PMID: 10601505 Free article. Clinical Trial.
Combination therapy with efavirenz, nelfinavir, and nucleoside reverse-transcriptase inhibitors in children infected with human immunodeficiency virus type 1. Pediatric AIDS Clinical Trials Group 382 Team.
Starr SE, Fletcher CV, Spector SA, Yong FH, Fenton T, Brundage RC, Manion D, Ruiz N, Gersten M, Becker M, McNamara J, Mofenson LM, Purdue L, Siminski S, Graham B, Kornhauser DM, Fiske W, Vincent C, Lischner HW, Dankner WM, Flynn PM. Starr SE, et al. Among authors: ruiz n. N Engl J Med. 1999 Dec 16;341(25):1874-81. doi: 10.1056/NEJM199912163412502. N Engl J Med. 1999. PMID: 10601506 Free article. Clinical Trial.
Therapy with efavirenz plus indinavir in patients with extensive prior nucleoside reverse-transcriptase inhibitor experience: a randomized, double-blind, placebo-controlled trial.
Haas DW, Fessel WJ, Delapenha RA, Kessler H, Seekins D, Kaplan M, Ruiz NM, Ploughman LM, Labriola DF, Manion DJ. Haas DW, et al. Among authors: ruiz nm. J Infect Dis. 2001 Feb 1;183(3):392-400. doi: 10.1086/318083. Epub 2000 Dec 29. J Infect Dis. 2001. PMID: 11133370 Clinical Trial.
Clinical history of efavirenz.
Ruiz N. Ruiz N. Int J Clin Pract Suppl. 1999 Jun;103:3-7. Int J Clin Pract Suppl. 1999. PMID: 10622035 Review.
Efficacy testing of recombinant human immunodeficiency virus (HIV) gp160 as a therapeutic vaccine in early-stage HIV-1-infected volunteers. rgp160 Phase II Vaccine Investigators.
Birx DL, Loomis-Price LD, Aronson N, Brundage J, Davis C, Deyton L, Garner R, Gordin F, Henry D, Holloway W, Kerkering T, Luskin-Hawk R, McNeil J, Michael N, Foster Pierce P, Poretz D, Ratto-Kim S, Renzullo P, Ruiz N, Sitz K, Smith G, Tacket C, Thompson M, Tramont E, Yangco B, Yarrish R, Redfield RR. Birx DL, et al. Among authors: ruiz n. J Infect Dis. 2000 Mar;181(3):881-9. doi: 10.1086/315308. J Infect Dis. 2000. PMID: 10720508 Clinical Trial.
Determining the relative efficacy of highly active antiretroviral therapy.
Louie M, Hogan C, Di Mascio M, Hurley A, Simon V, Rooney J, Ruiz N, Brun S, Sun E, Perelson AS, Ho DD, Markowitz M. Louie M, et al. Among authors: ruiz n. J Infect Dis. 2003 Mar 15;187(6):896-900. doi: 10.1086/368164. Epub 2003 Mar 6. J Infect Dis. 2003. PMID: 12660935 Clinical Trial.
Transmitted HIV type 1 drug resistance in newly diagnosed Cuban patients.
Machado LY, Dubed M, Díaz H, Ruiz N, Romay D, Váldes N, Blanco M, Silva E. Machado LY, et al. Among authors: ruiz n. AIDS Res Hum Retroviruses. 2013 Feb;29(2):411-4. doi: 10.1089/AID.2012.0183. Epub 2012 Oct 25. AIDS Res Hum Retroviruses. 2013. PMID: 22985307
325 results